Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
about
The endocannabinoid system as an emerging target of pharmacotherapyPostsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens.Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease.Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs.Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors.Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicleThe therapeutic potential of cannabinoids for movement disorders.Blocking TRPV1 in nucleus accumbens inhibits persistent morphine conditioned place preference expression in ratsPromising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionNew insights on endocannabinoid transmission in psychomotor disorders.Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis.Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling.The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in ratsThe endocannabinoid system as a target for the treatment of motor dysfunction.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Dopamine and glutamate in Huntington's disease: A balancing act.Endocannabinoid modulation of dopaminergic motor circuits.Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons.Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.Endocannabinoid system in neurodegenerative disorders.Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease.Endocannabinoid System and TRPV1 Receptors in the Dorsal Hippocampus of the Rats Modulate Anxiety-like BehaviorsThe bright side of psychoactive substances: cannabinoid-based drugs in motor diseases.Anandamide serves two masters in the brain.Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats.Differential treatment regimen-related effects of HU210 on CB(1) and D(2)-like receptor functionality in the rat basal ganglia.Endocannabinoids and Schizophrenia.
P2860
Q24648473-9EFA8574-ED93-44A7-965A-FD432FE4A730Q30500199-947371FE-CC02-453B-B38B-FE55C6B34AC8Q30844366-925405B2-501B-4F8B-B2D6-0DB5012C31BBQ33299388-99E2E9BD-FEDE-43BA-8080-C1E419B0B9E9Q33819365-D10BD1FA-215A-40B2-B1D0-7595F5E9E513Q33964434-F2EEAB8E-843D-497D-9137-07D9FD92FD24Q35162907-DD68F725-4677-44A6-B375-A5743EF6D89BQ35171113-0543C5E9-5EE6-485C-B587-996D8DEEEA5FQ35223978-150E8DBE-8B3D-4544-86ED-1CE97A264970Q35499568-01FCD225-595A-4BB4-B82D-D523187621FEQ36074595-3302E0A2-3229-4D72-900D-A170523E93CDQ36197937-15A9F1D1-DC1B-4233-9111-E6B9DACDC54CQ36715987-8EE080AC-B571-40F0-B609-06A2F28DCC2BQ36943239-A2BE685D-1A5F-4B53-99ED-3DFBD323BFF6Q37224649-CEE31603-8973-40E4-A568-163D09BECB31Q37394164-12519157-8E89-4A9C-9DCC-6A6006C3D69DQ37512670-2E03DF14-0D81-4CE6-9D64-55F1B201814FQ37734563-90E1AF11-7D2A-45EF-9C07-AA924E06CD72Q38018946-0E9BB286-4B99-4FBE-827A-5D98447A9BEAQ38341513-403664E0-5425-4296-95B8-DD8FBA99C0D3Q38522769-A5E5AB48-E73A-4CD2-8B33-EB75295F6DD3Q39368845-C91B846A-A62F-4B6F-AF34-99CDB62B73E1Q39507813-1D075EA2-0065-4661-8FE0-123425BA0765Q41807144-439E1102-FA85-4B2E-AE80-4D4257AA0814Q42495608-C920E322-4B97-422E-87A7-821A2BE45C32Q42794000-DE7C4EB9-FDBB-4FBE-9F40-A5E70CF87B96Q48485540-2DCD6FF7-B440-4678-B50F-E8B38DF8B323Q48678685-053E1419-B7E3-4282-AFD4-E59BFBF9ED75Q55452539-09BE464A-08AF-4EB9-95ED-67B0B72CA2BF
P2860
Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Involvement of vanilloid-like ...... in vivo and in vitro evidence.
@en
Involvement of vanilloid-like ...... in vivo and in vitro evidence.
@nl
type
label
Involvement of vanilloid-like ...... in vivo and in vitro evidence.
@en
Involvement of vanilloid-like ...... in vivo and in vitro evidence.
@nl
prefLabel
Involvement of vanilloid-like ...... in vivo and in vitro evidence.
@en
Involvement of vanilloid-like ...... in vivo and in vitro evidence.
@nl
P2093
P921
P1433
P1476
Involvement of vanilloid-like ...... in vivo and in vitro evidence
@en
P2093
Javier Fernández-Ruiz
José A Ramos
Rosario de Miguel
P304
P356
10.1016/J.BRAINRES.2004.02.016
P407
P577
2004-05-01T00:00:00Z